Rokos Capital Management (UK)’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,331,405
Closed -$60.5M 87
2023
Q3
$60.5M Sell
5,331,405
-833,787
-14% -$9.68M 0.44% 31
2023
Q2
$61.8M Hold
6,165,192
0.6% 25
2023
Q1
$56.8M Buy
6,165,192
+2,145,652
+53% +$25.3M 4.2% 7
2022
Q4
$48.8M Buy
4,019,540
+3,474,101
+637% +$43.3M 2.14% 11
2022
Q3
$7.06M Hold
545,439
0.21% 57
2022
Q2
$10.6M Hold
545,439
0.31% 49
2022
Q1
$14.7M Buy
+545,439
New +$14.5M 0.69% 24

Other funds holding ELAN

Rokos Capital Management (UK)'s ELAN Position: Q4 2023 in Review

Rokos Capital Management (UK) sold out of Elanco Animal Health (ELAN) in Q4 2023, closing a stake of 5,331,405 shares — an estimated $60.5M sold.

Rokos Capital Management (UK) first reported a position in ELAN in Q1 2022 and held it in 7 quarters. The position peaked at $61.8M in Q2 2023. 355 funds tracked by Wall St. Rank hold ELAN as of Q4 2023.

  • Rokos Capital Management (UK) reported no remaining Elanco Animal Health position as of Q4 2023 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 5,331,405 Elanco Animal Health shares in Q4 2023, an estimated $60.5M.
  • Rokos Capital Management (UK) first reported a position in Elanco Animal Health in Q1 2022 and held it in 7 quarters.
  • Rokos Capital Management (UK)'s Elanco Animal Health position peaked at $61.8M in Q2 2023.
  • 355 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2023.

Based on Rokos Capital Management (UK)'s 13F filing for Q4 2023, filed 14 Feb 2024.